The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.
Zepbound is a medication containing tirzepatide, which the preliminary study showed to be more effective for weight loss than Wegovy, which contains semaglutide. This preliminary study ...
Research consistently suggests people with overweight or obesity have more average weight loss on Zepbound than a placebo. The active ingredient in Zepbound is tirzepatide, which falls into ...
Wegovy (semaglutide) and Zepbound (tirzepatide) both target a group ... was linked to more weight loss than Wegovy, but until now, no studies have compared the two medications directly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback